Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Exchange Rate Effect (2023 - 2025)

Iovance Biotherapeutics (IOVA) has disclosed Exchange Rate Effect for 3 consecutive years, with $577000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 148.98% to $577000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 311.46% increase, with the full-year FY2025 number at $1.1 million, up 311.46% from a year prior.
  • Exchange Rate Effect was $577000.0 for Q4 2025 at Iovance Biotherapeutics, up from -$680000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $3.0 million in Q4 2023 to a low of -$3.8 million in Q2 2023.
  • A 3-year average of -$194272.7 and a median of -$125000.0 in 2024 define the central range for Exchange Rate Effect.
  • Biggest YoY gain for Exchange Rate Effect was 691.2% in 2025; the steepest drop was 154.27% in 2025.
  • Iovance Biotherapeutics' Exchange Rate Effect stood at $3.0 million in 2023, then crashed by 138.99% to -$1.2 million in 2024, then soared by 148.98% to $577000.0 in 2025.
  • Per Business Quant, the three most recent readings for IOVA's Exchange Rate Effect are $577000.0 (Q4 2025), -$680000.0 (Q3 2025), and $739000.0 (Q2 2025).